CARs are synthetic receptors that typically contain the following parts: an antibody-derived targeting ectodomain that recognizes tumor antigens; a costimulatory molecule region that can bind to receptors such as CD28, 4-1BB, or CD278;220 and a T cell signaling domain. Here, TNFRSF9 is linked to neoplasm.